ETF市场周报 | 市场风险偏好明显提振！沪指剑指 3500点，创新药ETF反弹明显

Market Overview - Global stock markets showed improved risk appetite due to the easing Middle East tensions and expectations of overseas interest rate cuts, with the S&P 500 and Nasdaq indices reaching historical highs [1] - A-shares strengthened significantly, driven by the financial sector, with the Shanghai Composite Index breaking through its year-to-date high, targeting 3500 points [1] - Major A-share indices experienced broad gains, with the Shanghai Composite Index, Shenzhen Component Index, and ChiNext Index rising by 1.40%, 1.25%, and 1.50% respectively [1] ETF Performance - The overall performance of growth sectors outperformed value sectors, with the average decline of all ETFs at 0.96%, while stock ETFs gained an average of 1.13% [1] - The innovative drug ETFs saw significant rebounds, with the top-performing ETF, the Hong Kong Innovative Drug ETF (520700), increasing by 7.55% [1] - Conversely, internet-related ETFs in Hong Kong faced declines, with the top decliner, the Hong Kong Internet ETF (159792), dropping by 3.73% [2] Policy Impact on Innovative Drugs - The release of several policies by the National Healthcare Security Administration and the National Health Commission is expected to significantly benefit the innovative drug sector, broadening market access and encouraging pharmaceutical companies to enhance R&D efforts [2] - The introduction of a commercial health insurance directory for innovative drugs marks a crucial step in the multi-tiered medical insurance system, potentially expanding the market space for innovative drugs [2] Fund Flow Trends - The ETF market saw a net inflow of 3.97 billion yuan, with bond ETFs attracting significant interest, particularly the Company Bond ETF (511110) and Silver Hua Daily ETF (211880), which saw inflows of 16.79 billion yuan and 15.62 billion yuan respectively [5] - High-growth ETFs also received considerable inflows, with the Sci-Tech Chip ETF (588200) and Photovoltaic ETF (515790) attracting 14.40 billion yuan and 12.32 billion yuan respectively [5] Upcoming ETF Listings - Six new ETFs are set to be listed next week, including the E Fund National Value 100 ETF (159263) and the Sci-Tech Enhanced ETF (588520), which aim to track indices focused on value and technology sectors respectively [8][9] - The Hong Kong Automotive ETF (159237) will track the performance of 50 listed companies in the automotive industry, reflecting the sector's dynamics [9][10] Long-term Outlook for Innovative Drugs - The innovative drug sector is viewed as a high-growth area within the pharmaceutical industry, with global market trends indicating that innovative drugs will constitute a significant portion of the overall pharmaceutical market by 2024 [12] - The global pharmaceutical market is projected to reach 16.4 trillion yuan, with innovative drugs accounting for approximately 1.13 trillion yuan, representing 68.9% of the market [12]